The Brigham and Women's Hospital, Inc.;Board of Regents, The University of Texas System
发明人:
申请号：
EP16177820.4
公开号：
EP3138915A1
申请日:
2011.05.04
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Methods of treating a subject having fibrosis or at risk of developing fibrosis by administering a Cadherin-11 (CDH11) antagonist are provided. The treatment may be administered to subjects with dermal or non-dermal fibrosis, including lung, liver or kidney fibrosis or idiopathic pulmonary fibrosis. Methods of assessing the levels of CDH11 in a subject and determining fibrosis or risk of developing fibrosis are also provided.
